Abstract:Abstract Objectives: Idiopathic inflammatory myopathies (IIM) are a group of refractory systemic autoimmune diseases with unknown pathogenesis, including dermatomyositis (DM) and polymyositis (PM). DNA methylation is an important epigenetic mechanism to regulate gene expression, which plays important roles in IIM. Integrated analysis of the whole-genome DNA methylation and gene expression profiling will provide a comprehensive understanding of the pathogenesis of IIM. Methods: We performed whole-genome DNA methylation and transcription analysis in peripheral blood of 16 DM patients, 8 PM patients and 16 normal controls (NC) using Illumina Human Methyation 450K Beadchips and Illumina Human HT-12 v4.0 Expression Beadchips. Luminex multiplex assay was used to quantify 27 cytokine/chemokine in sera of 30 DM, 16 PM and 237 NC. Genome Studio was used to identify differential DNA methylation and mRNA transcription. Integrative analysis of DNA methylome, mRNA transcriptome and serum cytokines were performed using R, Perl and Circos software. Bioinformatic analysis were performed using DAVID and R. Real-time PCR, Bisulfite pyrosequencing and immunofluorescence were used for validation. Results: Genome-wide DNA methylation analysis identified 241 differential methylated CpG sites (74 hypermethylated and 167 hypomethylated) in DM, and 500 differential methylated CpG sites (153 hypermethylated and 347 hypomethylated) in PM. Transcriptome analysis identified 540 differential expressed genes (277 upregulated and 263 downregulated ) in DM and 242 differential expressed genes (181 upregulated and 61 downregulated) in PM. Integrated analysis of DNA methylome with transcriptome suggested a significant inverse-correlation between DNA methylation and gene expression. 93 upregulated genes associated with hypomethylated CpG sites while 176 down-regulated genes related with hypermethylated CpG sites both DM and PM. Analysis of the DNA methylation and mRNA transcription data identified differential methylated CpG sites and differential expressed genes which are shared and/or unique between DM and PM. Bioinformatics analysis suggested that dysregulated genes which are shared between DM and PM participated in common biologic process, such as immune response, inflammatory response and defense response. However, differential genes which are unique in DM and PM were found to be enriched in type I interferon signaling pathway and cytokine pathway, respectively. 18 interferon related genes were upregulated and hypomethylated, IL-5 was increased and hypomethylated, PDGF-BB was decreased and hypermethylated both in DM and PM. Real-time PCR and bisulfite pyrosequencing validated 13 top changed methylation sites and genes, and showed significant correlation between DNA methylation status and gene expression in most genes. Conclusions: Our study identified differentially methylated CpG sites which have potential regulatory effects on differential gene expression in DM and PM. We also revealed dysregulated CpG sites and genes involved in common and specific biologic process in DM and PM. Type I interferon signaling pathway was significantly enrichment in DM while Cytokine signaling pathway was significantly enrichment in PM. Our observations have laid the groundwork for further diagnostic and mechanistic studies of DM and PM.

A Combined Genome-Wide Dna Methylation and Mrna Expression Analysis Identified Aberrant Gene Regulatory Pathways in Inflammatory Myositis

Polymyositis and Dermatomyositis Biomarkers

Genome-wide DNA Methylation and Mrna Transcription Analysis Revealed Aberrant Gene Regulation Pathways in Dermatomyositis and Polymyositis Patients

MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies

[Advances in epigenetic markers of dermatomyositis/polymyositis]

Coexpression Network Analysis Coupled with Connectivity Map Database Mining Reveals Novel Genetic Biomarkers and Potential Therapeutic Drugs for Polymyositis

The Expression of Cytokine Profiles and Related Receptors in Idiopathic Inflammatory Myopathies

Identification of Feature Genes and Key Biological Pathways in Immune-Mediated Necrotizing Myopathy: High-Throughput Sequencing and Bioinformatics Analysis

Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach

The muscle tissue transcriptome of idiopathic inflammatory myopathy reflects the muscle damage process by monocytes and presence of skin lesions

Meta‐analyses uncover the genetic architecture of Idiopathic Inflammatory Myopathies

Comprehensive Transcriptomic Analysis and Machine Learning Reveal Unique Gene Expression Profiles in Patients with Immune-Mediated Necrotizing Myopathy.

Characterised Intron Retention Profiles in Muscle Tissue of Idiopathic Inflammatory Myopathy Subtypes.

POS0851 IDENTIFICATION OF HUB GENES AND PATHWAYS IN DERMATOMYOSITIS BY BIOINFORMATICS ANALYSIS

Serum metabolomic analysis reveals disorder of steroid hormone biosynthesis in patients with idiopathic inflammatory myopathy

Integrated Comparison of the Mirnaome and Mrnaome in Muscles of Dermatomyositis and Polymyositis Reveals Common and Specific Mirna-Mrnas.

Using Multi-Omics Methods to Understand Dermatomyositis/polymyositis.

Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis

Metabolic Profiling of Patients with Different Idiopathic Inflammatory Myopathy Subtypes Reveals Potential Biomarkers in Plasma

Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies

Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis